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Abstract
The aim of the investigation is to develop the safe model of HIV infection to assess the efficacy
of antiretroviral drugs. Materials and methods. The HIV infection model was designed on the
basis of human cell culture and recombinant lentivirus carrying the gene of green fluorescent
protein (gfp). Recombinant lentivirus has the structure of 1 type HIV (HIV-1) from which genomic
RNA  was  removed  from using  genetic  engineering  method.  Cell  provirus  integration  was
assessed by gfp gene expression. By means of the model the activity of known medical drugs
used for HIV infection treatment was determined. Results. The model simulates three stages of
HIV-1 cycle: reverse transcription, pre-integration complex formation and its delivery to the
nucleus, provirus integration into cell genome. Nucleoside (Zidovudine and Lamivudine) and
non-nucleoside (Efavirenz)  inhibitors  of  reverse transcriptase effecting at  the stage of  HIV
reverse transcription, significantly suppressed provirus integration into human cell  genome,
while fusion inhibitor (Enfuvirtide) and HIV protease inhibitor (Atazanavir) did not have such an
effect as they act only at later stages not represented in the model. Conclusion. The suggested
model can be used not only for pharmaceuticals testing but also for screening new modalities of
having an effect on human cells including gene therapy.
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